WallStreetZenWallStreetZen

NASDAQ: SNDX
SYNDAX PHARMACEUTICALS INC Stock Forecast, Predictions & Price Target

Analyst price target for SNDX

Based on 4 analysts offering 12 month price targets for SYNDAX PHARMACEUTICALS INC.
Min Forecast
$21.00+48.2%
Avg Forecast
$28.25+99.36%
Max Forecast
$37.00+161.12%

Should I buy or sell SNDX stock?

Based on 4 analysts offering ratings for SYNDAX PHARMACEUTICALS INC.
Strong Buy
Strong Buy
2 analysts 50%
Buy
1 analysts 25%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

SNDX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Anonymous
Goldman Sachs
Strong BuyMaintains$40.00+182.29%2022-05-24
HC Wainwright & Co.
Bottom 25%
25
BuyInitiates Coverage On$31.00+118.77%2022-04-11
Goldman Sachs
Top 2%
99
Strong BuyInitiates Coverage On$37.00+161.12%2022-02-15
Morgan Stanley
Top 30%
71
HoldMaintains$21.00+48.20%2021-10-12
Citigroup
Bottom 4%
4
Strong BuyInitiates Coverage On$24.00+69.37%2021-05-25

1 of 1

Forecast return on equity

Is SNDX forecast to generate an efficient return?
Company
-24.32%
Industry
78.55%
Market
30.86%
SNDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SNDX forecast to generate an efficient return on assets?
Company
-21.58%
Industry
21.31%
SNDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SNDX earnings per share forecast

What is SNDX's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$2.81-820.51%
Avg 2 year Forecast
-$3.21-923.08%
Avg 3 year Forecast
-$1.14-392.31%

SNDX revenue forecast

What is SNDX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$5.0M-96.41%
Avg 2 year Forecast
$15.0M-89.23%
Avg 3 year Forecast
$148.5M+6.56%
SNDX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SNDX revenue growth forecast

How is SNDX forecast to perform vs Biotechnology companies and vs the US market?
Company
-0.5%
Industry
17.95%
Market
8.91%
SNDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SNDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SNDX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SNDX$14.17$28.25+99.36%Strong Buy
FGEN$8.52$24.75+190.49%Hold
ACRS$11.92$40.00+235.57%Strong Buy
MIRM$25.26$56.50+123.67%Strong Buy
SANA$4.24$13.67+222.31%Buy

SYNDAX PHARMACEUTICALS Stock Forecast FAQ

Is SYNDAX PHARMACEUTICALS Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: SNDX) stock is to Strong Buy SNDX stock.

Out of 4 analysts, 2 (50%) are recommending SNDX as a Strong Buy, 1 (25%) are recommending SNDX as a Buy, 1 (25%) are recommending SNDX as a Hold, 0 (0%) are recommending SNDX as a Sell, and 0 (0%) are recommending SNDX as a Strong Sell.

What is SNDX's earnings growth forecast for 2022-2024?

(NASDAQ: SNDX) SYNDAX PHARMACEUTICALS's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.71%.

SYNDAX PHARMACEUTICALS's earnings in 2022 is $15,480,000.On average, 3 Wall Street analysts forecast SNDX's earnings for 2022 to be -$158,012,836, with the lowest SNDX earnings forecast at -$173,195,564, and the highest SNDX earnings forecast at -$149,015,664. On average, 3 Wall Street analysts forecast SNDX's earnings for 2023 to be -$180,505,766, with the lowest SNDX earnings forecast at -$193,439,201, and the highest SNDX earnings forecast at -$171,508,594.

In 2024, SNDX is forecast to generate -$64,104,852 in earnings, with the lowest earnings forecast at -$69,728,084 and the highest earnings forecast at -$59,043,942.

What is SNDX's revenue growth forecast for 2022-2024?

(NASDAQ: SNDX) SYNDAX PHARMACEUTICALS's forecast annual revenue growth rate of -0.5% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 17.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.91%.

SYNDAX PHARMACEUTICALS's revenue in 2022 is $139,330,000.On average, 1 Wall Street analysts forecast SNDX's revenue for 2022 to be $281,161,630, with the lowest SNDX revenue forecast at $281,161,630, and the highest SNDX revenue forecast at $281,161,630. On average, 1 Wall Street analysts forecast SNDX's revenue for 2023 to be $843,484,890, with the lowest SNDX revenue forecast at $843,484,890, and the highest SNDX revenue forecast at $843,484,890.

In 2024, SNDX is forecast to generate $8,348,813,441 in revenue, with the lowest revenue forecast at $8,105,327,470 and the highest revenue forecast at $8,592,299,413.

What is SNDX's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: SNDX) forecast ROA is -21.58%, which is lower than the forecast US Biotechnology industry average of 21.31%.

What is SNDX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year SNDX price target, the average SNDX price target is $28.25, with the highest SNDX stock price forecast at $37.00 and the lowest SNDX stock price forecast at $21.00.

On average, Wall Street analysts predict that SYNDAX PHARMACEUTICALS's share price could reach $28.25 by Apr 11, 2023. The average SYNDAX PHARMACEUTICALS stock price prediction forecasts a potential upside of 99.36% from the current SNDX share price of $14.17.

What is SNDX's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: SNDX) SYNDAX PHARMACEUTICALS's current Earnings Per Share (EPS) is $0.39. On average, analysts forecast that SNDX's EPS will be -$2.81 for 2022, with the lowest EPS forecast at -$3.08, and the highest EPS forecast at -$2.65. On average, analysts forecast that SNDX's EPS will be -$3.21 for 2023, with the lowest EPS forecast at -$3.44, and the highest EPS forecast at -$3.05. In 2024, SNDX's EPS is forecast to hit -$1.14 (min: -$1.24, max: -$1.05).

What is SNDX's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: SNDX) forecast ROE is -24.32%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.